| G04BE07 |
G04BE07 Apomorphine |
| G04BE08 |
G04BE08 Tadalafil |
| G04BE09 |
G04BE09 Vardenafil |
| G04BE10 |
G04BE10 Avanafil |
| G04BE11 |
G04BE11 Udenafil |
| G04BE30 |
G04BE30 Combinations |
| G04BE52 |
G04BE52 Papaverine, combinations |
| G04BX |
G04BX Other urologicals |
| G04BX01 |
G04BX01 Magnesium hydroxide |
| G04BX03 |
G04BX03 Acetohydroxamic acid |
| G04BX06 |
G04BX06 Phenazopyridine |
| G04BX10 |
G04BX10 Succinimide |
| G04BX11 |
G04BX11 Collagen |
| G04BX12 |
G04BX12 Phenyl salicylate |
| G04BX13 |
G04BX13 Dimethyl sulfoxide |
| G04BX14 |
G04BX14 Dapoxetine |
| G04BX15 |
G04BX15 Pentosan polysulfate sodium |
| G04BX16 |
G04BX16 Tiopronin |
| G04C |
G04C Drugs used in benign prostatic hypertrophy |
| G04CA |
G04CA Alpha-adrenoreceptor antagonists |
| G04CA01 |
G04CA01 Alfuzosin |
| G04CA02 |
G04CA02 Tamsulosin |
| G04CA03 |
G04CA03 Terazosin |
| G04CA04 |
G04CA04 Silodosin |
| G04CA51 |
G04CA51 Alfuzosin and finasteride |
| G04CA52 |
G04CA52 Tamsulosin and dutasteride |
| G04CA53 |
G04CA53 Tamsulosin and solifenacin |
| G04CA54 |
G04CA54 Tamsulosin And Tadalafil |
| G04CB |
G04CB Testosterone-5-alpha reductase inhibitors |
| G04CB01 |
G04CB01 Finasteride |